More on PEN
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $323.56 |
|
|||
| Open | $323.50 | ||||
| 52 Wk High | $79.49 | ||||
| 52 Wk Low | $40.23 | ||||
| Day High | $325.39 | ||||
| Day Low | $323.50 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 279,795 | ||||
- Penumbra wins FDA clearance for DVT treatment technology
- Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
- Form 4 Penumbra Inc For: Oct 15 Filed by: Narayan Shruthi
- New STORM-PE Data Demonstrate Correlation Between Clinical Assessments and Real-world Functional Recovery Captured Through Wearable Technology in Patients with Pulmonary Embolism
- Form 4 Penumbra Inc For: Sep 15 Filed by: Narayan Shruthi
- Form 4 Penumbra Inc For: Aug 17 Filed by: Narayan Shruthi
- Form SCHEDULE 13G Penumbra Inc Filed by: BARCLAYS PLC
- Penumbra, Inc. (PEN) Misses Q2 EPS by 28c
- Form 10-Q Penumbra Inc For: Jun 30
- Form 8-K Penumbra Inc For: Jul 30
Entities mentioned with PEN
- Earnings | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Twitter | View Related Stories »
- Definitive Agreement | View Related Stories »
- JPMorgan | View Related Stories »
- FDA | View Related Stories »
- Show More...
